Multisystem Impact in Hereditary Angioedema

Written by Margaret Anne Rockwood | Last updated September 8th, 2026
Medically reviewed by Timothy J. Craig, DO

Hereditary angioedema (HAE) is often recognized by dramatic swelling of any skin
surface, such as the hands, feet, genitalia, face, or lips, but its effects are not limited to the skin. Episodic increases in vascular permeability can also allow fluid to accumulate in subcutaneous tissues, affecting the gastrointestinal tract and upper airway. Counterintuitively, HAE attacks can erupt in one or more of these organ systems with little external manifestation.

In isolation, internal swelling may be mistaken for signs of another disorder and, in the
case of upper-airway involvement, can become life-threatening. Thus, assessing for
multisystem manifestations is crucial.

Cutaneous and Subcutaneous Manifestations

Peripheral swelling is among the most recognizable manifestations of HAE. Attacks
commonly affect the hands, feet, arms, legs, genitalia, face, and trunk. The edema is generally nonpruritic and is typically not accompanied by urticaria, helping distinguishHAE from histamine-mediated allergic angioedema.

Swelling is asymmetric and can involve different locations during an attack. Patients may experience tightness, discomfort, pain, or temporary functional limitations – for example, difficulty walking when a foot is affected, or using the hands during significant hand swelling.

Some individuals may develop erythema marginatum, a transient, nonpruritic,
serpiginous (winding, curving) rash that can precede or accompany an attack and may
occur in isolation. Because HAE can be confused with urticaria, recognizing erythema
marginatum as a possible HAE-associated finding can be diagnostically useful.

Gastrointestinal Involvement

Gastrointestinal (GI) involvement is one of the most important, and sometimes
underrecognized, manifestations of HAE. Edema of the bowel wall can produce severe,
episodic abdominal symptoms. In one analysis of HAE attacks, almost half of the
attacks evaluated involved abdominal symptoms alone. Common manifestations
included abdominal distention, cramping, nausea, and vomiting.

Patients may experience:

• severe or colicky abdominal pain
• abdominal distention
• nausea and vomiting
• diarrhea
• fluid accumulation within the abdomen (ascites)
• dehydration or, in severe attacks, circulatory compromise

A large analysis evaluating more than 33,000 abdominal attacks confirmed that
recurrent abdominal attacks are a major manifestation of HAE due to C1-inhibitor
deficiency.

Importantly, an abdominal attack may occur without visible swelling elsewhere on the
body, which can also complicate diagnosis.

Acute HAE-related abdominal pain may resemble appendicitis, bowel obstruction,
pancreatitis, or other causes of an acute abdomen, sometimes resulting in unnecessary diagnostic procedures or surgery.

For patients with known HAE, clinicians should therefore consider an abdominal HAE
attack when otherwise unexplained, recurrent GI symptoms follow the patient’s characteristic attack pattern.

Note that both bowel-wall edema and ascites can occur simultaneously in HAE. A CT
scan might show:

• segmental small-bowel wall edema
• mesenteric edema
• moderate ascites

Increased vascular permeability can cause each of these findings.

Upper Airway and Oropharyngeal Involvement (Laryngeal Attacks)

Swelling involving the tongue, pharynx, or larynx represents the most dangerous
manifestation of HAE because progressive edema can obstruct the airway. Symptoms
that warrant particular attention include voice changes, throat tightness, difficulty
swallowing, tongue swelling, noisy breathing, or breathing difficulty.

Although less common than peripheral or abdominal attacks, laryngeal edema generally
represents the most serious complication of HAE because of the potential for airway
obstruction and asphyxiation. Symptoms may include:

• throat tightness
• dysphagia
• voice changes
• hoarseness
• stridor
• progressive respiratory distress

Although laryngeal attacks account for a relatively small proportion of total attacks, they
can progress to fatal asphyxiation if not recognized and treated promptly.

Sources

• Bork K, Staubach P, Eckardt AJ, Hardt J. Symptoms, course, and complications
  of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am
  J Gastroenterol. 2006;101(3):619-627.
• Jalaj S, Scolapio JS. Gastrointestinal manifestations, diagnosis, and
  management of hereditary angioedema. J Clin Gastroenterol. 2013;47(10):817-
  823.
• Martinez-Saguer I, Farkas H. Erythema marginatum as an early symptom of
  hereditary angioedema: case report of 2 newborns. Pediatrics.
  2016;137(2):e20152411.
• Maurer M, Magerl M, Betschel S, et al. The international WAO/EAACI guideline
  for the management of hereditary angioedema—the 2021 revision and update.
  World Allergy Organ J. 2022;15(3):100627.
• Obtułowicz P, Stobiecki M, Dyga W, et al. Abdominal and pelvic imaging in the
  diagnosis of acute abdominal attacks in patients with hereditary angioedema due
  to C1-inhibitor deficiency. Adv Dermatol Allergol. 2022;39(4):687-693.
• Rubinstein E, Stolz LE, Sheffer AL, Stevens C, Bousvaros A. Abdominal attacks
  and treatment in hereditary angioedema with C1-inhibitor deficiency. BMC
  Gastroenterol. 2014;14:71.
• Vázquez DO, Giavina-Bianchi P, Josviack D, et al. The 2025 WAO guidelines for
  the classification, diagnosis, and treatment of hereditary angioedema, with
  consideration of worldwide disparities. World Allergy Organ J.
  2026;19(5):101335.